SCHEMBL6566010

SCHEMBL6566010

COC(=O)c1cc(N)ccc1OC(c1ccccc1)c1ccc(Cl)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
TDO2 P48775 1/20 0.48
ABL1 P00519 1/20 0.42
PYGL P06737 1/20 0.41
NPSR1 Q6W5P4 3/20 0.39
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
POLB P06746 1/20 0.38
PPARA Q07869 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565892 0.90 IDO1 (0.44) IDO1TDO2ABL1ALDH1A1L3MBTL1
SCHEMBL6567929 0.88 ABL1 (0.40) IDO1TDO2ABL1PYGLALDH1A1
SCHEMBL6565805 0.88 ABL1 (0.44) IDO1TDO2ABL1PYGLNPSR1
SCHEMBL6565855 0.86 ABL1 (0.42) ABL1NPSR1ALDH1A1L3MBTL1GAA
SCHEMBL6564533 0.85 GAA (0.48) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL6566844 0.84 TDP1 (0.45) IDO1TDO2PYGLALDH1A1MEN1
SCHEMBL6564515 0.83 IDO1 (0.46) IDO1TDO2ALDH1A1GAAKDM4E
SCHEMBL6567926 0.82 HPGD (0.42) IDO1TDO2ALDH1A1GAAKDM4E
SCHEMBL6567822 0.82 ABL1 (0.39) IDO1TDO2ABL1ALDH1A1GAA
SCHEMBL6564793 0.81 MEN1 (0.49) NPSR1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 IDO1 953/4885TDO2 675/4885ABL1 2094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.